Herbalife (HLF) Could Be 23% Undervalued Despite Sluggish Growth And Weaker Earnings
Recent commentary on Herbalife (HLF) is centered on sluggish organic revenue growth and a weakening earnings trend, prompting fresh questions about how much risk is already reflected in the current share price.
The recent 1.6% one-day share price return to US$13.03 extends a mild positive trend over the past month, even as the 90-day share price return is slightly down. That sits against a very strong 1-year total shareholder return of 51.5%, but a much weaker 5-year total shareholder return, which shows how sentiment around Herbalife has swung between renewed optimism and long-running concerns about the business trajectory.
Balance that mixed Herbalife story by scanning a hand-picked 28 high quality undervalued stocks with stronger trends in revenue and earnings quality.
A 51.5% one year return followed by a modest uptick to US$13.03 tempts some Herbalife holders to press their advantage. Others would rather wait for more clarity. Which camp does the current valuation support?
Most Popular Herbalife Narrative: 23% Undervalued
The most followed narrative now pegs Herbalife's fair value at $17 per share compared with the latest close of $13.03. This frames the recent rebound inside a still cautious but supportive valuation story built on cash generation, capital structure repair and digital nutrition plans.
Stronger free cash generation, lower leverage following approximately US$540 million of debt repayment since early 2024, interest savings of about US$45 million a year from the 2026 refinancing, and the addition of a US$250 million three year buyback program alongside planned further debt reduction can increase flexibility for capital deployment, which may support earnings per share and reduce equity risk premia embedded in Herbalife’s valuation.
See why 9 investors see Herbalife as 23% undervalued.
Result: Fair Value of $17 (UNDERVALUED)
Still, the Herbalife story can break if China and EMEA weakness deepens, or if emerging market mix pressure keeps eroding gross margins and squeezes earnings expectations.
Find out about the key risks to this Herbalife narrative.
Next Steps
Mixed signals around Herbalife can leave you undecided, so move quickly, review the underlying data, and balance its 3 key rewards and 4 important warning signs.
Looking for more Herbalife-sized opportunities?
If Herbalife has sharpened your thinking, do not stop here. Broaden your watchlist with fresh ideas that match your risk appetite and income goals.
- Target potential turnaround upside by reviewing tightly selected smaller companies through the 14 elite penny stocks with strong financials that already show stronger financial foundations.
- Focus on value and quality together by scanning the 28 high quality undervalued stocks that pair healthier balance sheets with more consistent operating performance.
- Prioritize staying power over drama by using a 31 resilient stocks with low risk scores that highlights businesses with sturdier fundamentals and fewer red flags.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com